Storm Warning: Lung Disease in Systemic Juvenile Idiopathic Arthritis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Storm Warning: Lung Disease in Systemic Juvenile Idiopathic Arthritis
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-08-07
DOI
10.1002/art.41071
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study
- (2019) Nienke M. ter Haar et al. Arthritis & Rheumatology
- Interleukin-18 in pediatric rheumatic diseases
- (2019) Giusi Prencipe et al. CURRENT OPINION IN RHEUMATOLOGY
- Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
- (2016) Claudia Bracaglia et al. ANNALS OF THE RHEUMATIC DISEASES
- Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses
- (2016) Katrin D Mayer-Barber et al. Cellular & Molecular Immunology
- Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
- (2016) Gillian I. Rice et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IL-1α induces CD11blowalveolar macrophage proliferation and maturation during granuloma formation
- (2015) François Huaux et al. JOURNAL OF PATHOLOGY
- T-cell-restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung
- (2014) S. Iriguchi et al. BLOOD
- Patients with Very Early-onset Systemic Juvenile Idiopathic Arthritis Exhibit More Inflammatory Features and a Worse Outcome
- (2013) R. A. G. RUSSO et al. JOURNAL OF RHEUMATOLOGY
- Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles
- (2012) Masaki Shimizu et al. CYTOKINE
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis
- (2012) Yukiko Kimura et al. ARTHRITIS CARE & RESEARCH
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series
- (2010) Peter A. Nigrovic et al. ARTHRITIS AND RHEUMATISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started